Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus

The clinical trial of allogenic mesenchymal stem cells (MSCs) transplantation for refractory SLE patients has shown significant safety and efficacy profiles. However, the optimum frequency of the MSCs transplantation (MSCT) is unknown. This study was undertaken to observe whether double transplantat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wang, Dandan, Akiyama, Kentaro, Zhang, Huayong, Yamaza, Takayoshi, Li, Xia, Feng, Xuebing, Wang, Hong, Hua, Bingzhu, Liu, Bujun, Xu, Huji, Chen, Wanjun, Shi, Songtao, Sun, Lingyun
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2012
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399403/
https://ncbi.nlm.nih.gov/pubmed/22829849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/273291
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires